Vitrolife Q4: Continues to stabilise an improved growth momentum - Redeye

Vitrolife continues stabilise its growth rate and is approaching high single-digit growth. The Q4 6% outcome is still far from the long-term objective of >10% but is another step in the right direction. Strong areas include EMEA, Americas, Consumables and Technologies. Together with a positive gross margin surprise, this will likely trigger a positive share price reaction.

Länk till analysen i sin helhet: https://www.redeye.se/research/1070757/vitrolife-q4-continues-to-stabilise-an-improved-growth-momentum?utm_source=finwire&utm_medium=RSS